{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T15:46:46Z","timestamp":1781970406538,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Consejer\u00eda de Educaci\u00f3n, Ciencia y Formaci\u00f3n Profesional of Junta de Extremadura","award":["GR24210"],"award-info":[{"award-number":["GR24210"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Prostatic artery embolization (PAE) has received attention to manage the urological symptoms in patients with prostate cancer (PCa). This meta-analysis evaluates its effectiveness and safety in patients with PCa.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Material and Methods<\/jats:title>\n            <jats:p>A systematic review was performed by searching in PudMed and Web of Science databases for studies including either PAE or prostatic artery chemoembolization (PACE) in patients with PCa. Quantitative and qualitative analyses were performed. The primary outcomes were technical success, clinical success, oncological efficacy and adverse events (AEs). The secondary outcomes were International Prostate Symptoms Score (IPSS), quality of life (QoL), prostate volume (PV), and prostate-specific antigen (PSA).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Eleven single-arm studies with 151 participants were included. The pooled technical and clinical success rates were 95.53% (95%CI: 87.23, 99.95) and 90.31% (95%CI: 73.44, 99.85), respectively, whereas the oncological efficacy was 65.89% (95%CI: 32.18, 93.13). AEs showed low rates of minor 23.88% (95%CI: 8.88, 42.39) and major 0.6% (95%CI: 0.00, 3.67). Although, PAE tended to fewer AEs compared to PACE, 20.76% vs 31.03% for minor, and 1.01% vs 0.32% for major AEs, respectively. In addition, there was a statistically significant reduction in IPSS (\u2212\u200910.24, 95%CI: \u2212\u200914.60,\u2212\u20095.89), QoL (\u2212\u20092.28, 95%CI: \u2212\u20093.25, \u2212\u20091.32), PV (\u2212\u200922.16, 95%CI: \u2212\u200934.20, \u2212\u200910.13), and PSA (\u2212\u20097.32, 95%CI: \u2212\u200912.34, \u2212\u20092.29), with greater improvements after PACE. Overall, the studies showed a high risk of bias.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This meta-analysis revealed that PAE and PACE are feasible, effective, and safe techniques to control the urological symptoms in patients with PCa, and even as adyuvant treatment for local therapies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1007\/s00270-025-04107-6","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T17:05:48Z","timestamp":1752167148000},"page":"1263-1277","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effectiveness and Safety of Prostatic Artery Embolization for Patients with Prostate Cancer: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9807-386X","authenticated-orcid":false,"given":"Vanesa","family":"Lucas-Cava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Miguel","family":"S\u00e1nchez-Margallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"4107_CR1","unstructured":"N. Mottet, P. Cornford, R.C.N. van den Bergh, E. Briers, D. Eberli, G. De Meerleer, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer 2023. Eur Assoc Urol [Internet]. 2023;1\u2013234. Available from: https:\/\/uroweb.org\/guidelines\/prostate-cancer\/chapter\/treatment"},{"issue":"2","key":"4107_CR2","first-page":"345","volume":"11","author":"CS McNevin","year":"2021","unstructured":"McNevin CS, Baird A-M, McDermott R, Finn SP. Diagnostic strategies for treatment selection in advanced prostate cancer. Diagnostics (Basel, Switzerland). 2021;11(2):345.","journal-title":"Diagnostics (Basel, Switzerland)."},{"issue":"9","key":"4107_CR3","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s00270-022-03165-4","volume":"45","author":"I Insausti","year":"2022","unstructured":"Insausti I, Galbete A, Lucas-Cava V, de Oc\u00e1riz AS, Solchaga S, Monreal R, de la Cuesta AM, Alfaro R, Sun F, Montesino M, Urtasun F, Jauregu\u00edzar J. Prostatic artery embolization (PAE) using polyethylene glycol microspheres: safety and efficacy in 81 patients. Cardiovasc Intervent Radiol. 2022;45(9):1339\u201348.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"8","key":"4107_CR4","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.jvir.2016.04.001","volume":"27","author":"JM Pisco","year":"2016","unstructured":"Pisco JM, Bilhim T, Pinheiro LC, Fernandes L, Pereira J, Costa NV, Duarte M, Oliveira A. Medium- and long-term outcome of prostate artery embolization for patients with benign prostatic hyperplasia: results in 630 patients. J Vasc Interv Radiol. 2016;27(8):1115\u201322.","journal-title":"J Vasc Interv Radiol"},{"issue":"5","key":"4107_CR5","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.jvir.2019.02.008","volume":"30","author":"W Tian","year":"2019","unstructured":"Tian W, Zhou C, Leng B, Shi H, Liu S. Prostatic artery embolization for control of gross hematuria in patients with benign prostatic hyperplasia: a single-center retrospective study in 20 patients. J Vasc Interv Radiol. 2019;30(5):661\u20137. https:\/\/doi.org\/10.1016\/j.jvir.2019.02.008.","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"4107_CR6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jvir.2012.12.019","volume":"24","author":"FC Carnevale","year":"2013","unstructured":"Carnevale FC, da Motta-Leal-Filho JM, Antunes AA, Baroni RH, Marcelino AS, Cerri LM, Yoshinaga EM, Cerri GG, Srougi M. Quality of life and clinical symptom improvement support prostatic artery embolization for patients with acute urinary retention caused by benign prostatic hyperplasia. J Vasc Interv Radiol. 2013;24(4):535\u201342.","journal-title":"J Vasc Interv Radiol"},{"issue":"10","key":"4107_CR7","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s00270-019-02227-4","volume":"42","author":"B Malling","year":"2019","unstructured":"Malling B, R\u00f8der MA, Lindh M, Frevert S, Brasso K, L\u00f6nn L. Palliative prostate artery embolization for prostate cancer: a case series. Cardiovasc Intervent Radiol. 2019;42(10):1405\u201312.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"7","key":"4107_CR8","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.jvir.2021.03.534","volume":"32","author":"N Parikh","year":"2021","unstructured":"Parikh N, Keshishian E, Manley B, Grass GD, Torres-Roca J, Boulware D, et al. Effectiveness and safety of prostatic artery embolization for the treatment of lower urinary tract symptoms from benign prostatic hyperplasia in men with concurrent localized prostate cancer. J Vasc Interv Radiol. 2021;32(7):1053\u201361.","journal-title":"J Vasc Interv Radiol"},{"issue":"6","key":"4107_CR9","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00270-024-03679-z","volume":"47","author":"O Burkhardt","year":"2024","unstructured":"Burkhardt O, Abt D, Hechelhammer L, Kim O, Omlin A, Schmid H-P, et al. Prostatic artery embolization in patients with advanced prostate cancer: a prospective single center pilot study. Cardiovasc Intervent Radiol. 2024;47(6):771\u201382.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"3","key":"4107_CR10","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.brachy.2021.12.004","volume":"21","author":"H Haddad","year":"2022","unstructured":"Haddad H, Hermani H, Bischoff P, Hanitzsch H, Heidrich A, Schaefer A, et al. Permanent interstitial brachytherapy for prostate cancer implementing neoadjuvant prostatic artery embolization. Brachytherapy. 2022;21(3):308\u201316.","journal-title":"Brachytherapy"},{"issue":"5","key":"4107_CR11","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jvir.2018.01.766","volume":"29","author":"L Mordasini","year":"2018","unstructured":"Mordasini L, Hechelhammer L, Diener P-A, Diebold J, Mattei A, Engeler D, et al. Prostatic artery embolization in the treatment of localized prostate cancer: a bicentric prospective proof-of-concept study of 12 patients. J Vasc Interv Radiol. 2018;29(5):589\u201397.","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"4107_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart L. Preferred reporting items for systematic review and meta-analysis protocols (prisma-p) 2015 statement. Syst Rev. 2015;4(1):1.","journal-title":"Syst Rev"},{"key":"4107_CR13","first-page":"4","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:4\u201310.","journal-title":"BMJ"},{"issue":"1","key":"4107_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1411","volume":"12","author":"LA McGuinness","year":"2021","unstructured":"McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021;12(1):55\u201361.","journal-title":"Res Synth Methods."},{"issue":"2","key":"4107_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jvir.2020.10.002","volume":"32","author":"J Frandon","year":"2021","unstructured":"Frandon J, Bey E, Hamard A, Mohammad H, Gonzalez S, Greffier J, et al. Early results of unilateral prostatic artery embolization as a focal therapy in patients with prostate cancer under active surveillance: cancer prostate embolisation, a pilot study. J Vasc Interv Radiol. 2021;32(2):247\u201355.","journal-title":"J Vasc Interv Radiol"},{"key":"4107_CR16","doi-asserted-by":"publisher","first-page":"205846011984606","DOI":"10.1177\/2058460119846061","volume":"8","author":"CR Tapping","year":"2019","unstructured":"Tapping CR, Crew J, Proteroe A, Boardman P. Prostatic artery embolization (PAE) for prostatic origin bleeding in the context of prostate malignancy. Acta radiologica open. 2019;8:2058460119846061.","journal-title":"Acta radiologica open."},{"issue":"2","key":"4107_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jvir.2016.10.010","volume":"28","author":"J-W Chen","year":"2017","unstructured":"Chen J-W, Shin JH, Tsao T-F, Ko H-G, Yoon H-K, Han K-C, et al. Prostatic arterial embolization for control of hematuria in patients with advanced prostate cancer. J Vasc Interv Radiol. 2017;28(2):295\u2013301.","journal-title":"J Vasc Interv Radiol"},{"issue":"3","key":"4107_CR18","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jvir.2017.10.013","volume":"29","author":"J Pisco","year":"2018","unstructured":"Pisco J, Bilhim T, Costa NV, Ribeiro MP, Fernandes L, Oliveira AG. Safety and efficacy of prostatic artery chemoembolization for prostate cancer\u2014initial experience. J Vasc Interv Radiol. 2018;29(3):298\u2013305.","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"4107_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41391-022-00516-7","volume":"26","author":"MQ Wang","year":"2023","unstructured":"Wang MQ, Zhang JL, Duan F, Yuan B, Xin H, Fu JX, et al. Prostate arterial chemoembolization for treatment of refractory hematuria and urinary retention in patients with localized advanced prostate cancer. Prostate Cancer Prostatic Dis. 2023;26(1):88\u201395.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"4","key":"4107_CR20","doi-asserted-by":"publisher","first-page":"480","DOI":"10.21037\/tau-22-189","volume":"11","author":"Y Guan","year":"2022","unstructured":"Guan Y, Wang W, Zhang T, Liao L, Chen J, Zhang Z, et al. Epirubicin-loaded beads transarterial prostatic arterial chemoembolization is a promising treatment for advanced prostate cancer with lower urinary tract obstruction or hematuria-a case series report. Transl Androl Urol. 2022;11(4):480\u201394.","journal-title":"Transl Androl Urol"},{"issue":"2","key":"4107_CR21","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.eururo.2015.02.029","volume":"68","author":"E Haglind","year":"2015","unstructured":"Haglind E, Carlsson S, Stranne J, Wallerstedt A, Wilder\u00e4ng U, Thorsteinsdottir T, et al. Urinary incontinence and erectile dysfunction after robotic versus open radical prostatectomy: a prospective, controlled. Nonrandomised Trial Eur Urol. 2015;68(2):216\u201325.","journal-title":"Nonrandomised Trial Eur Urol"},{"issue":"1","key":"4107_CR22","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1186\/s12885-019-6285-x","volume":"19","author":"W Guo","year":"2019","unstructured":"Guo W, Sun Y-C, Bi J-Q, He X-Y, Xiao L. Hypofractionated radiotherapy versus conventional radiotherapy in patients with intermediate- to high-risk localized prostate cancer: a meta-analysis of randomized controlled trials. BMC Cancer. 2019;19(1):1063.","journal-title":"BMC Cancer"},{"issue":"3","key":"4107_CR23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.euf.2023.02.005","volume":"10","author":"O Burkhardt","year":"2023","unstructured":"Burkhardt O, Abt D, Engeler D, Schmid H-P, M\u00fcllhaupt G, Zumstein V. Prostatic artery embolization in patients with prostate cancer: a systematic review. Eur Urol Focus. 2023;10(3):387\u201399.","journal-title":"Eur Urol Focus"},{"issue":"3","key":"4107_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvir.2020.100687","volume":"23","author":"JJ Manov","year":"2020","unstructured":"Manov JJ, Mohan PP, Kava B, Bhatia S. Benign prostatic hyperplasia: a brief overview of pathogenesis, diagnosis, and current state of therapy. Tech Vasc Interv Radiol. 2020;23(3): 100687.","journal-title":"Tech Vasc Interv Radiol"},{"issue":"1","key":"4107_CR25","doi-asserted-by":"publisher","first-page":"65a","DOI":"10.3390\/jcm13010065","volume":"13","author":"L Moramarco","year":"2023","unstructured":"Moramarco L, Grande AM, Vertemati M, Aseni P. Prostate artery embolization in the treatment of massive intractable bleeding from prostatic neoplasms: a case report and systematic review. J Clin Med. 2023;13(1):65a.","journal-title":"J Clin Med"},{"issue":"4","key":"4107_CR26","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1007\/s00270-013-0611-5","volume":"36","author":"AA Antunes","year":"2013","unstructured":"Antunes AA, Carnevale FC, da Leal M, Filho JM, Yoshinaga EM, Cerri LM, Baroni RH, Marcelino AS, Cerri GG, Srougi M. Clinical, laboratorial, and urodynamic findings of prostatic artery embolization for the treatment of urinary retention related to benign prostatic hyperplasia. a prospective single-center pilot study. Cardiovasc Intervent Radiol. 2013;36(4):978\u201386.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1","key":"4107_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12894-020-00726-y","volume":"20","author":"AS Somwaru","year":"2020","unstructured":"Somwaru AS, Metting S, Flisnik LM, Nellamattathil MG, Sharma A, Katabathina VS. Prostate artery embolization has long term efficacy for treatment of severe lower urinary tract symptoms from giant prostatic hyperplasia. BMC Urol. 2020;20(1):1\u20139.","journal-title":"BMC Urol"},{"issue":"1","key":"4107_CR28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/bju.13147","volume":"117","author":"M Wang","year":"2016","unstructured":"Wang M, Guo L, Duan F, Yuan K, Zhang G, Li K, Yan J, Wang Y, Kang H. Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates. BJU Int. 2016;117(1):155\u201364.","journal-title":"BJU Int"},{"issue":"5","key":"4107_CR29","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.adro.2020.03.015","volume":"5","author":"N Parikh","year":"2020","unstructured":"Parikh N, Keshishian E, Sharma A, Roca M, Manley B, Poch M, et al. Prostatic artery embolization is safe and effective for medically recalcitrant radiation-induced prostatitis. Adv Radiat Oncol. 2020;5(5):905\u20139.","journal-title":"Adv Radiat Oncol"},{"issue":"3","key":"4107_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2020.11.004","volume":"6","author":"J Peacock","year":"2021","unstructured":"Peacock J, Sikariam D, Maun-Garcia L, Javedan K, Yamoah K, Parikh N, et al. A proof-of-concept study on the use of prostate artery embolization before definitive radiation therapy in prostate cancer. Adv Radiat Oncol. 2021;6(3): 100619.","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"4107_CR31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ajur.2016.09.011","volume":"4","author":"G Gaunay","year":"2017","unstructured":"Gaunay G, Patel V, Shah P, Moreira D, Hall SJ, Vira MA, et al. Role of multi-parametric MRI of the prostate for screening and staging: experience with over 1500 cases. Asian J Urol. 2017;4(1):68\u201374.","journal-title":"Asian J Urol"},{"issue":"3","key":"4107_CR32","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jvir.2017.11.006","volume":"29","author":"SH Culp","year":"2018","unstructured":"Culp SH. Prostatic artery chemoembolization-a viable management option for men diagnosed with prostate cancer? J Vasc Interv Radiol. 2018;29(3):306.","journal-title":"J Vasc Interv Radiol"},{"issue":"5","key":"4107_CR33","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10147-010-0181-3","volume":"16","author":"A Seki","year":"2011","unstructured":"Seki A, Hori S. Transcatheter arterial chemoembolization with docetaxel-loaded microspheres controls heavily pretreated unresectable liver metastases from colorectal cancer: a case study. Int J Clin Oncol. 2011;16(5):613\u20136.","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"4107_CR34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12876-024-03282-z","volume":"24","author":"G Wang","year":"2024","unstructured":"Wang G, Zhang J, Liu H, Zheng Q, Sun P. Embolization alone is as effective as TACE for unresectable HCC: systematic review and meta-analysis of randomized controlled trails. BMC Gastroenterol. 2024;24(1):195.","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"4107_CR35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00270-020-02657-5","volume":"44","author":"GM Knight","year":"2021","unstructured":"Knight GM, Talwar A, Salem R, Mouli S. Systematic review and meta-analysis comparing prostatic artery embolization to gold-standard transurethral resection of the prostate for benign prostatic hyperplasia. Cardiovasc Intervent Radiol. 2021;44(2):183\u201393.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"7","key":"4107_CR36","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.1007\/s00330-020-07663-2","volume":"31","author":"P Xiang","year":"2021","unstructured":"Xiang P, Guan D, Du Z, Hao Y, Yan W, Wang Y, Liu Y, Liu D, Ping H. Efficacy and safety of prostatic artery embolization for benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials. Eur Radiol. 2021;31(7):4929\u201346.","journal-title":"Eur Radiol"},{"key":"4107_CR37","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ WV (editors). Cochrane handbook for systematic reviews of interventions [Internet]. Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane. 2021. Available from: www.training.cochrane.org\/handbook"},{"issue":"8","key":"4107_CR38","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jclinepi.2006.11.003","volume":"60","author":"SD Walter","year":"2007","unstructured":"Walter SD, Yao X. Effect sizes can be calculated for studies reporting ranges for outcome variables in systematic reviews. J Clin Epidemiol. 2007;60(8):849\u201352.","journal-title":"J Clin Epidemiol"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-025-04107-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00270-025-04107-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-025-04107-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:00:28Z","timestamp":1758816028000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00270-025-04107-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":38,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["4107"],"URL":"https:\/\/doi.org\/10.1007\/s00270-025-04107-6","relation":{},"ISSN":["1432-086X"],"issn-type":[{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"21 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"For this type of study informed consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"For this type of study consent for publication is not required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}